GSK at ERS 2023
In Milan this September, we’ll join the world’s leading respiratory experts at the European Respiratory Society’s International Congress (ERS) where the latest advances in respiratory medicine and science will be showcased.
Over four days, we’ll be hosting eight symposia and sharing more than forty abstracts, conveying our commitment, expertise and ongoing innovation in the field of respiratory disease. We have ambitious goals to help protect patients and treat respiratory diseases like asthma, COPD, or rarer lung conditions with our range of innovative treatments including targeted biologics, vaccines and inhaled medicines.
The research presented will demonstrate the potential of GSK’s portfolio, the evolution of treatment management approaches, and key insights from the people affected by respiratory disease. Our portfolio of medicines, combined with robust clinical evidence and a personalised ‘treatable traits’ approach could improve the lives and outcomes of millions of people around the world affected by respiratory disease.
If you are a healthcare professional, you can learn more about our marketed products by selecting your market and the specific GSKPro website on our worldwide directory.
COPD & Asthma
Lucy and Peter reflect on living with asthma and COPD, but don’t let their respiratory conditions get in the way when they get the opportunity to try glass blowing for the first time.
Go behind the science
Discover how we’re uniting technology, science, and talent to help get ahead of respiratory disease.